Parallel Advisors’s Psyence Biomedical PBM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$575K Hold
151,250
– – 0.01% 760
2026
Q2
$575K Hold
151,250
– – 0.01% 729
2026
Q1
$575K Hold
151,250
– – 0.01% 670
2025
Q4
$687K Buy
151,250
+127,050
+525% +$1.89M 0.01% 575
2025
Q3
$687K Sell
24,200
-19,800
-45% -$544K 0.01% 554
2025
Q2
$462K Buy
+44,000
New +$1.22M 0.01% 664

Other funds holding PBM

Parallel Advisors's PBM Position: Q3 2026 in Review

Parallel Advisors held its Psyence Biomedical (PBM) position steady in Q3 2026 at 151,250 shares worth $575K. The position accounts for 0.01% of the portfolio, ranked #760.

Parallel Advisors first reported a position in PBM in Q2 2025 and has held it in 6 quarters since. The position peaked at $687K in Q4 2025. 10 funds tracked by Wall St. Rank hold PBM as of Q3 2026.

  • Parallel Advisors held 151,250 shares of Psyence Biomedical worth $575K as of Q3 2026.
  • Parallel Advisors left its Psyence Biomedical share count unchanged in Q3 2026.
  • Psyence Biomedical made up 0.01% of Parallel Advisors's portfolio in Q3 2026, its #760 holding.
  • Parallel Advisors first reported a position in Psyence Biomedical in Q2 2025 and has held it in 6 quarters since.
  • Parallel Advisors's Psyence Biomedical position peaked at $687K in Q4 2025.
  • 10 funds tracked by Wall St. Rank held Psyence Biomedical as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.